WS #10024

The dominant narrative remains the US-Iran deal, with new details emerging. A reported draft MOU outlines a ceasefire, $300B for Iran, $100B in frozen funds, oil waivers, and Hormuz traffic restoration, with nuclear issues deferred 60 days. However, document authenticity is disputed—Tasnim cites an Iranian source saying Bloomberg's version is inaccurate and the final MOU won't be public. Trump angrily defended the deal at the G7, belittling Obama's deal. G7 leaders agreed on joint stockpiling of critical minerals. Iraq takes steps to boost oil exports when Hormuz reopens. The IEA warned of a looming oil supply surplus in 2027, with supply rising 8M bpd vs demand growth of 2M bpd. US economic data beat expectations: Retail Sales +0.9% vs 0.5% est., Pending Home Sales +3.8% MoM. Fed Chair Warsh holds first press conference today; markets expect no rate change. SpaceX shares fell for the first time since IPO. uniQure shares surged after FDA reversal on Huntington's therapy. Snap shares fell on pushback over $2,195 AR glasses. Jabil shares rose on better-than-expected Q3 results and raised guidance. EIA crude inventories showed a larger-than-expected draw of 8.263M barrels vs 3.6M est. Trump invoked Defense Production Act for munitions supply chains. UK ordered Google to improve search transparency. The US-Iran deal narrative is ESCALATING with new draft details, but authenticity disputes add uncertainty.